885167-89-5 Usage
Uses
Used in Pharmaceutical Synthesis:
3-Chloro-4-formyl-2-methoxypyridine is utilized as an intermediate in the synthesis of pharmaceuticals, contributing to the development of new drugs. Its unique structure allows for versatile chemical modifications, making it a valuable component in medicinal chemistry.
Used in Agrochemical Production:
In the agrochemical industry, 3-chloro-4-formyl-2-methoxypyridine serves as an intermediate, playing a crucial role in the creation of pesticides and other agricultural chemicals. Its properties can be harnessed to enhance the effectiveness of these products.
Used in Biological Research:
3-Chloro-4-formyl-2-methoxypyridine has been studied for its potential biological activities, such as anti-inflammatory and anti-cancer properties. Researchers explore its capacity to modulate biological processes, offering insights into the development of therapeutic agents.
Used in Material Science:
As a building block in material science, 3-chloro-4-formyl-2-methoxypyridine is employed in the development of new materials and organic compounds. Its structural attributes make it a promising candidate for creating innovative materials with specialized properties for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 885167-89-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,1,6 and 7 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 885167-89:
(8*8)+(7*8)+(6*5)+(5*1)+(4*6)+(3*7)+(2*8)+(1*9)=225
225 % 10 = 5
So 885167-89-5 is a valid CAS Registry Number.
InChI:InChI=1/C7H6ClNO2/c1-11-7-6(8)5(4-10)2-3-9-7/h2-4H,1H3
885167-89-5Relevant academic research and scientific papers
SUBSTITUTED HETEROCYCLIC INHIBITORS OF PTPN11
-
Paragraph 0272-0273, (2019/11/19)
The present invention relates to compounds which may be useful as inhibitors of PTPN11 for the treatment or prevention of cancer and other PTP-mediated diseases. Disclosed herein are new compounds and compounds based on pyrazolopyrazines and their applica
HETEROCYCLIC INHIBITORS OF PTPN11
-
Paragraph 0368; 0369, (2018/01/04)
The present invention relates to compounds which may be useful as inhibitors of PTPN11 for the treatment or prevention of cancer and other PTP-mediated diseases. Disclosed herein are new compounds and compounds based on pyrazolopyrazines and their applica
